Torrent Pharmaceuticals is currently trading at Rs. 1342.35, up by 8.05 points or 0.60% from its previous closing of Rs. 1334.30 on the BSE.
The scrip opened at Rs. 1345.00 and has touched a high and low of Rs. 1374.80 and Rs. 1342.35 respectively.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1374.80 on 20-Jul-2015 and a 52 week low of Rs. 688.50 on 24-Jul-2014.
Last one week high and low of the scrip stood at Rs. 1374.80 and Rs. 1307.55 respectively. The current market cap of the company is Rs. 22,698.00 crore.
The promoters holding in the company stood at 71.25% while Institutions and Non-Institutions held 19.02% and 9.73% respectively.
Torrent Pharmaceuticals has concluded the acquisition of 100% stake in Zyg Pharma consequent to precedent and closing conditions which have been satisfied and the entire equity was transferred to the company on July 17, 2015.
The company had earlier on May 05, 2015 inked a Share Purchase Agreement (SPA) to acquire 100% stake in Zyg Pharma, a company engaged in manufacturing various dermatological formulations like creams, ointments, gels, lotions, solutions.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: